Expanding Manufacturing Capacity PharmaLogic is actively scaling its production capabilities with new facilities in Los Angeles and Salt Lake City, creating opportunities to offer its radiopharmaceutical manufacturing services to biotech and pharma companies seeking reliable cGMP-compliant partners in the US market.

Strategic Industry Collaborations Recent partnerships with companies like TAG1 Inc and Life Molecular Imaging highlight PharmaLogic’s commitment to expanding access to radiopharmaceutical diagnostics and therapeutics, indicating potential for further collaboration with industry innovators seeking development and distribution support.

Therapeutic Radiopharmaceutical Focus Being the only global CDMO producing and distributing a commercial radiopharmaceutical therapeutic across more than 30 countries positions PharmaLogic as a prime partner for organizations looking to expand their therapeutic radiopharmaceutical portfolio internationally.

High-Quality Regulatory Standards PharmaLogic’s adherence to cGMP and high regulatory standards demonstrates reliability and quality, making it an attractive manufacturing partner for companies requiring compliant production capacities for clinical and commercial radiopharmaceutical products.

Market Growth & Opportunities With a rapidly growing diagnostics division leveraging advanced technologies and expanding into oncology, cardiology, and Alzheimer’s disease, PharmaLogic presents multiple opportunities for sales of innovative radiopharmaceuticals, diagnostic agents, and custom manufacturing solutions tailored to emerging market needs.